The U.S. Food and Drug Administration (FDA) has acknowledged the filing for review of three New Drug Applications (NDAs) from Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc.
Keep Reading →
March 8 - News, Stock Analysis
Results for the Pfizer Inc.
Keep Reading →
February 28 - News, Stock Analysis
What are the 10 states with the highest opioid abuse rates? Opioid pain killers are generally a good thing.
Keep Reading →
February 26 - Lists, News
Pfizer Inc. (NYSE:PFE) is one of the world’s largest pharmaceutical firms with sales exceeding $50 billion.
Keep Reading →
February 22 - Dividend Stocks, News, Stock Analysis
Pfizer Inc. (NYSE:PFE) has been slapped with a warning letter by the Food and Drug Administration in regards to one of its fill/finish factories.
Keep Reading →
February 22 - News, Stock Analysis
I’ll start with LVMH Moet Hennessy Louis Vuitton SE (ADR) (OTCMKTS:LVMUY), the world’s largest fashion powerhouse… and also happens to be the maker of fine champagne.
Keep Reading →
February 14 - News, Stock Analysis
Pfizer Inc. (NYSE:PFE) and Citibank have agreed to work together in the acceleration of share repurchase, which will involve buying back of Pfizer’s common stock.
Keep Reading →
February 7 - News, Stock Analysis
The National Institute for Health and Care Excellence (NICE) has declared the latest breast cancer drug too expensive to justify its use.
Keep Reading →
February 3 - News, Stock Analysis
Did you know five of the 11 largest pharmaceutical companies in the world are US companies? The healthcare and pharmaceutical sector is one of the safest stock market sectors ...
Keep Reading →
January 26 - Lists, News
The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and the prevalence is especially...
Keep Reading →
January 17 - Lists, News
Investor sell or write a call options over stocks they own in exchange for collecting a premium.
Keep Reading →
January 17 - News, Options, Stock Analysis
If you search for the biggest problems in the world that can be solved with inventions in Google, all you get is a bunch of articles that mention inventions that deal with tiny...
Keep Reading →
January 10 - Lists, News
Pfizer Inc. (NYSE:PFE) is stepping up its battle against breast cancer.
Keep Reading →
January 10 - News, Stock Analysis
It takes a lot of guts for an individual to stand up against huge corporate entities for the overall well-being of the society.
Keep Reading →
December 30 - Lists, News
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences, Inc.
Keep Reading →
December 23 - News, Stock Analysis
The U.S. Food and Drug Administration (FDA) has agreed to review a supplemental New Drug Application (sNDA) of CDK 4/6 inhibitor, IBRANCE (palbociclib) from Pfizer Inc.
Keep Reading →
December 22 - News, Stock Analysis
There is a need for additional funding towards the development and clinical studies of AndexXa, a new compound that is a prospective antidote for Factor Xa inhibitors.
Keep Reading →
December 20 - News, Stock Analysis
Renaissance Technologies is probably the best quant hedge fund in the market.
Keep Reading →
December 2 - Hedge Funds, News
Dividend stocks have become a favorite investment category in the last few years as central banks have supressed interest rates.
Keep Reading →
December 2 - Hedge Funds, News
Maverick Capital Ltd. is an investment advisor and private investment fund that uses a Long/short approach to invest in equity products.
Keep Reading →
December 1 - Hedge Funds, News
Given that the latest batch of 13F filings has just been released and collective hedge fund activity can sometimes presage future stock moves, Insider Monkey has compiled a list...
Keep Reading →
November 28 - Hedge Funds, News
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources...
Keep Reading →
November 23 - Hedge Funds, News
Pfizer Inc. (NYSE:PFE) has confirmed its collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), on immunotherapy development.
Keep Reading →
November 16 - News, Stock Analysis
Crude futures are lower today as traders brace for the upcoming OPEC meeting later this month.
Keep Reading →
November 10 - Market Movers, News
Pfizer Inc. (NYSE:PFE) has recently revealed that it is closing two manufacturing plants in Britain.
Keep Reading →
November 9 - News
Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109 as the Oldest Money Manager...
Keep Reading →
November 8 - Hedge Fund Analysis, Hedge Funds, News
Novartis AG (ADR) (NYSE:NVS) CDK4/6 breast cancer drug remains on track with Pfizer Inc. (NYSE:PFE)'s Ibrance.
Keep Reading →
November 2 - News
Ken Fisher runs Fisher Asset Management, a hedge fund which manages a portfolio worth over $65.44 billion. Mr. Fisher has authored several books, including 6 best-sellers.
Keep Reading →
October 21 - Dividend Stocks, Hedge Fund Analysis, Hedge Funds, News
Although the earnings reports of various tech companies have mostly commanded the spotlight this Tuesday, the shares of five companies, Visa Inc (NYSE:V), Johnson & Johnson (...
Keep Reading →
October 18 - Earnings Report, News
With interest rates at their lowest point in history, once safe income-producing assets such as 10- and 30-year Treasury bonds have seen their yields plunge to pitiful rates that...
Keep Reading →
October 14 - Dividend Stocks, News
Pfizer was incorporated in 1942 and today is a global biopharmaceutical company with operations all across the globe.
Keep Reading →
October 12 - Dividend Stocks, News, Stock Analysis
The broader indexes are in the red today as some traders take profits before Friday's critical employment report. Among the stocks making some headlines include Tesla Motors...
Keep Reading →
October 6 - Market Movers, News
We are now into the final quarter of 2016, and there looks set to be plenty of activity across the biotech space before the year draws to a close.
Keep Reading →
October 5 - News
After opening well in the green, all three indexes are now close to flat as traders weigh various bits of macro-economic data. Although the U.S.
Keep Reading →
September 28 - Market Movers, News, Tech
Among the stocks that are grabbing attention today are major names such as Pfizer Inc. (NYSE:PFE), Deutsche Bank AG (USA) (NYSE:DB), Netflix, Inc.
Keep Reading →
September 26 - Market Movers, News
Crude futures are in the green this morning after Iran said that it welcomed "any move aimed at market stability and improvement of oil prices based on justice, fairness and fair...
Keep Reading →
September 19 - Market Movers, News
In this article, we'll examine five stocks that investors are eagerly watching this weekend, which are GoPro Inc (NASDAQ:GPRO), Pfizer Inc.
Keep Reading →
September 18 - Market Movers, News
On September 14, the Food and Drug Administration released two briefing documents for the joint meeting of two committees.
Keep Reading →
September 16 - News, Stock Analysis
Among the stocks commanding the spotlight today are Wells Fargo & Co (NYSE:WFC), Twitter Inc (NYSE:TWTR), CLARCOR Inc. (NYSE:CLC), Pfizer Inc.
Keep Reading →
September 15 - Market Movers, News
Dividends are a shareholder's best friend.
Keep Reading →
September 9 - Dividend Stocks, Hedge Funds, News
In this low interest rate environment, dependable, wide-moat dividend stocks are in high demand.
Keep Reading →
September 6 - Dividend Stocks, Hedge Funds, News
Times are tough for healthcare stocks as investors keep a distance from the sector following drug-pricing control concerns and political clamor.
Keep Reading →
August 29 - Hedge Funds, News
The healthcare sector had one of its worst years in almost a decade last year when several big names from the space saw their stocks plunge dramatically.
Keep Reading →
August 25 - Hedge Funds, News
One of our many regular quarterly features at Insider Monkey is to present a series of articles detailing groups of stocks which saw large increases or decreases in the hedge ...
Keep Reading →
August 24 - Hedge Funds, News
Maverick Capital is a long/short equity hedge fund founded by billionaire Lee S. Ainslie III in 1993.
Keep Reading →
August 23 - Hedge Fund Analysis, Hedge Funds, News
After surging almost non-stop to $49 per barrel from $40, WTI futures are now 2% in the red while the broader indexes are pretty much flat in pre-market trading on the first trading...
Keep Reading →
August 22 - Market Movers, News
A protege of billionaire Carl Icahn, Keith Meister founded Corvex Capital in 2011, managing to attract $250 million in seed money from George Soros.
Keep Reading →
August 18 - Hedge Fund Analysis, Hedge Funds, News
